Kirsten Craven

Choosing the right LC-MS system for bioanalysis: Let’s make it easier

Dec 23, 2025 | Blogs, Pharma, QTRAP / Triple Quad | 0 comments

Read time: 3 minutes

Investing in a new liquid chromatography-mass spectrometry (LC-MS) system is a big decision, especially when your lab handles a wide variety of analytical tasks. With so many options out there, it’s easy to feel overwhelmed.

That’s where this blog comes in. We’ll walk you through the bioanalytical quantitation solutions offered by SCIEX, helping you better understand which system might be the best fit for your current needs and future ambitions.

SCIEX doesn’t offer a one-size-fits-all approach. There are several LC-MS systems, each with its own strengths. So, whether you’re focused on today’s workflows or planning for tomorrow’s challenges, there’s a solution that aligns with your goals.

Let’s dig into this in more detail because life is never this simple.

Routine bioanalysis

When it comes to bioanalysis, SCIEX has been a trusted name in quadrupole mass spectrometry for as long as most of us can remember. But it’s not just about the hardware. We’re proud of the reliability, support, and innovation that come with every LC-MS system we offer.

All our instruments run on SCIEX OS software, a powerful yet intuitive platform designed to simplify your workflow. Whether you’re working in a regulated environment or not, using compliance-ready software from the start can be a smart move. It helps streamline method development and makes future transitions into regulated bioanalytical spaces smoother and faster.

Here is an example of the performance you can expect from the system, Highly sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma using the SCIEX QTRAP 6500 System

Routine bioanalysis requiring higher sensitivity

As technology has developed, mass spectrometers have become more sensitive and what was considered a nice-to-have feature is now often essential. If you need to see trace-level analytes or your matrices are very complex, the 7500+ system is the better option for you.

Curious to see examples of what the 7500+ system can do?

Sensitive quantitation of glucagon-like peptide-1 (GLP-1) analog in rat plasma

Comprehensive LC-MS workflows for antibody drug conjugate (ADC) analysis

Flexible Quant/Qual system, more selectivity, or larger analytes

In the last 5 years, improvements in the quantitative performance and sensitivity of time-of-flight (TOF) technology has made it more attractive to bioanalysis labs. The ability to offer both quantitation and qualitative information on a single system makes life easier. Also, as drug modalities have changed and test compounds have become larger, they have exceeded the mass range of quadrupole systems making a TOF essential.

Additional benefits of a TOF are increased selectivity allowing low-level analytes to be distinguished from complex matrices. This can allow for shorter run times and reduced sample preparation.

Discover more about how the ZenoTOF 7600 could help in your lab, here:

Sensitive quantification of insulin lispro using accurate mass spectrometry (sciex.com)

High resolution LC-MS/MS solution for improved quantitation of peptides in a complex matrix

For more information on the options SCIEX has for bioanalysis please speak to your account manager or this technology pack may be of interest to you, New Frontiers in Bioanalysis.

Why not join the Mass spec bioanalysis community on LinkedIn?

The community offers the opportunity to:

Connect with experts and peers in the field
Share and discuss the latest approaches and methodologies
Post your job adverts and look for new positions to forward your career in bioanalysis
Stay updated on industry trends, events, and conferences

Follow the link to join, here

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

ADC analytics FAQs: Answering the most common questions about ADC characterization

Antibody-drug conjugates (ADCs) have emerged as one of the fastest-growing classes of biotherapeutics, combining the targeting specificity of monoclonal antibodies with the potency of cytotoxic payloads. However, this unique architecture also introduces significant analytical complexity. From drug-to-antibody ratio (DAR) distributions and charge variants to conjugation sites and structural modifications, ADCs present multiple, interconnected sources of heterogeneity that must be understood to ensure product quality and performance.

Sterile but toxic: Cereulide detection in food matrices

In a recent webinar, Ming Gao, Ph.D., Senior Research Chemist at Mérieux NutriSciences, explored the growing challenge of cereulide contamination in food products and the analytical strategies needed to detect this heat-stable toxin at trace levels. The session examined how LC-MS/MS can help laboratories overcome the limitations of traditional microbiological screening and meet emerging regulatory requirements.

Posted by

Kirsten Craven

Kirsten Craven is the Senior Global Marketing Manager for Pharma global strategic marketing at SCIEX. In this role, she manages strategic marketing for the pharmaceutical industry. Kirsten spent the first part of her career working in laboratories across multiple industries before moving into product management, and most recently pharma marketing.

0 Comments